litlas
Log inCreate account

Yue Xiong

Active 1988–2025

202
Papers
42,410
Citations
105
h-index
182
i10-index

Citations

Citations per year for Yue Xiong1987: 1 citations1988: 3 citations1989: 6 citations1990: 18 citations1991: 32 citations1992: 67 citations1993: 154 citations1994: 270 citations1995: 334 citations1996: 305 citations1997: 286 citations1998: 291 citations1999: 435 citations2000: 375 citations2001: 309 citations2002: 269 citations2003: 248 citations2004: 275 citations2005: 256 citations2006: 264 citations2007: 230 citations2008: 241 citations2009: 254 citations2010: 291 citations2011: 361 citations2012: 406 citations2013: 445 citations2014: 474 citations2015: 493 citations2016: 450 citations2017: 466 citations2018: 449 citations2019: 1,183 citations2020: 1,436 citations2021: 1,410 citations2022: 1,270 citations2023: 1,095 citations2024: 1,600 citations2025: 810 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,215 citing papers, 32.3% of this breakdownChina: 3,864 citing papers, 20% of this breakdownUnited Kingdom: 975 citing papers, 5.1% of this breakdownGermany: 885 citing papers, 4.6% of this breakdownJapan: 705 citing papers, 3.7% of this breakdownFrance: 584 citing papers, 3% of this breakdownCanada: 563 citing papers, 2.9% of this breakdownItaly: 530 citing papers, 2.7% of this breakdownSouth Korea: 359 citing papers, 1.9% of this breakdownSpain: 335 citing papers, 1.7% of this breakdownAustralia: 321 citing papers, 1.7% of this breakdownIndia: 321 citing papers, 1.7% of this breakdown
0%32.3%Other 18.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology51.2%
  • Medicine37.9%
  • Immunology and Microbiology3.9%
  • Agricultural and Biological Sciences3.1%
  • Neuroscience1.4%
  • Chemistry0.4%
  • Other2.1%

Topics

  • Cancer-related Molecular Pathways5.9%
  • Epigenetics and DNA Methylation5.2%
  • Ubiquitin and proteasome pathways4.9%
  • Cancer, Hypoxia, and Metabolism4.2%
  • RNA modifications and cancer2.9%
  • Hippo pathway signaling and YAP/TAZ2%
  • Other74.9%

Coauthors

All papers

Open in search
  1. Advancing targeted protein degradation for cancer therapy

    Authors: Brandon Dale, Meng Cheng, Kwang‐Su Park, H. Ümit Kanıskan, Yue Xiong, Jian Jin - Nature reviews. Cancer 2021 cited by 611

  2. Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

    Authors: Wei Xu, Hui Yang, Ying Liu, Ying Yang, Ping Wang, Se Hee Kim, Shinsuke Ito, Yang Chen, Pu Wang, Meng-Tao Xiao, Li-xia Liu, Wen-qing Jiang, Jing Liu, Jin-ye Zhang, Bin Wang, Stephen V. Frye, Yi Zhang, Yan-hui Xu, Qun‐Ying Lei, Kun‐Liang Guan, Shimin Zhao, Yue Xiong - Cancer Cell 2011 cited by 2,849

  3. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

    Authors: Mengtao Xiao, Hui Yang, Wei Xu, Shenghong Ma, Huaipeng Lin, Honguang Zhu, Lixia Liu, Ying Liu, Yang Chen, Yanhui Xu, Shimin Zhao, Dan Ye, Yue Xiong, Kun‐Liang Guan - Genes & Development 2012 cited by 1,132

  4. Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity

    Authors: Xiaoya Li, Tianxiang Wang, Xinmei Huang, Yue Li, Tiange Sun, Shufei Zang, Kun‐Liang Guan, Yue Xiong, Jun Liu, Hai‐Xin Yuan - Liver International 2020 cited by 277

  5. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy

    Authors: Yujia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Minjie Fu, Zhou‐Li Cheng, Zhen Yang, Gui‐Qi Zhu, Xudong Wang, Cheng Zhang, Jinye Zhang, Yiping Sun, Hexige Saiyin, Jin Zhang, Wei‐Ren Liu, Wenwei Zhu, Kun‐Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Leilei Chen - Science Advances 2023 cited by 143

  6. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses

    Authors: Leilei Chen, Carmen Morcelle, Zhou‐Li Cheng, Xiufei Chen, Yanping Xu, Yajing Gao, Junbin Song, Zhijun Li, Matthew D. Smith, Miao Shi, Yezhang Zhu, Neng Zhou, Meng Cheng, Chenxi He, Kwei‐Yan Liu, Guoping Lü, Lei Zhang, Cheng Zhang, Jinye Zhang, Yiping Sun, Tuan Qi, Yingying Lyu, Zhizhong Ren, Xianming Tan, Jiayong Yin, Fei Lan, Ying Liu, Hui Yang, Maoxiang Qian, Cai‐Wen Duan, Xing Chang, Yufeng Zhou, Li Shen, Albert S. Baldwin, Kun‐Liang Guan, Yue Xiong, Dan Ye - Nature Cell Biology 2022 cited by 206

  7. Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets

    Authors: Yan Xiong, Yue Zhong, Hyerin Yim, Xiaobao Yang, Kwang‐Su Park, Ling Xie, Poulikos I. Poulikakos, Xiaoran Han, Yue Xiong, Xian Chen, Jing Liu, Jian Jin - Journal of the American Chemical Society 2022 cited by 129

  8. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer

    Authors: Xiufei Chen, Meng‐Xin Tian, Renqiang Sun, Mengli Zhang, Lisha Zhou, Lei Jin, Lei‐Lei Chen, Wen‐Jie Zhou, Kun‐Long Duan, Yu‐Jia Chen, Chao Gao, Zhou‐Li Cheng, Fang Wang, Jinye Zhang, Yi‐Ping Sun, Hongxiu Yu, Yuzheng Zhao, Yi Yang, Weiren Liu, Ying–Hong Shi, Yue Xiong, Kun‐Liang Guan, Dan Ye - EMBO Reports 2018 cited by 281

  9. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis

    Authors: Renqiang Sun, Zhiyong Zhang, Ruoxuan Bao, Xiaozhen Guo, Yuan Gu, Wenjing Yang, Jinsong Wei, Xinyu Chen, Lingfeng Tong, Jianping Meng, Chen Zhong, Cheng Zhang, Jinye Zhang, Yiping Sun, Chen Ling, Xuemei Tong, Fa‐Xing Yu, Hongxiu Yu, Wei‐Feng Qu, Bing Zhao, Wei Guo, Maoxiang Qian, Hexige Saiyin, Ying Liu, Ronghua Liu, Cen Xie, Weiren Liu, Yue Xiong, Kun‐Liang Guan, Ying–Hong Shi, Pu Wang, Dan Ye - Journal of Hepatology 2022 cited by 188

  10. Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth

    Authors: Lei Lv, Li Dong, Di Zhao, Ruiting Lin, Yajing Chu, Heng Zhang, Zhengyu Zha, Ying Liu, Zi Li, Yanping Xu, Gang Wang, Yong Huang, Yue Xiong, Kun‐Liang Guan, Qun‐Ying Lei - Molecular Cell 2011 cited by 599

  11. Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy

    Authors: Yanping Xu, Lei Lv, Ying Liu, Matthew D. Smith, Wencai Li, Xianming Tan, Meng Cheng, Zhijun Li, Michael Bovino, Jeffrey Aubé, Yue Xiong - Journal of Clinical Investigation 2019 cited by 226

  12. TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway

    Authors: Qun‐Ying Lei, Heng Zhang, Bin Zhao, Zhengyu Zha, Feng Bai, Xin‐Hai Pei, Shimin Zhao, Yue Xiong, Kun‐Liang Guan - Molecular and Cellular Biology 2008 cited by 922

  13. Mitogenic and Oncogenic Stimulation of K433 Acetylation Promotes PKM2 Protein Kinase Activity and Nuclear Localization

    Authors: Lei Lv, Yan-Ping Xu, Di Zhao, Fu-Long Li, Wei Wang, Naoya Sasaki, Ying Jiang, Xin Zhou, Ting-Ting Li, Kun‐Liang Guan, Qun‐Ying Lei, Yue Xiong - Molecular Cell 2013 cited by 332

  14. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS

    Authors: Jinye Zhang, Kun‐Liang Guan, Yaohui Chen, Shimin Zhao, Qun‐Ying Lei, Yue Xiong, Yan Lin - EMBO Reports 2011 cited by 552

  15. BTB Protein Keap1 Targets Antioxidant Transcription Factor Nrf2 for Ubiquitination by the Cullin 3-Roc1 Ligase

    Authors: Manabu Furukawa, Yue Xiong - Molecular and Cellular Biology 2004 cited by 733

  16. TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition

    Authors: Qun‐Ying Lei, Kun‐Liang Guan, Heng Zhang, Bin Zhao, Yue Xiong, Jun Yao, Chen Ying Liu, Shimin Zhao, Zheng Zha - Journal of Biological Chemistry 2009 cited by 568

  17. Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer

    Authors: Ping Wang, Yue Xiong, Qun‐Ying Lei, Kun‐Liang Guan, Ying Liu, Xin Zhou, Yan Hui Xu, Di Zhao, Yan Mo, Shao Wu Zou, Bo Dong - Cancer Cell 2013 cited by 342

  18. Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder

    Authors: Yue Xiong, Jianhui Chen, Yingbo Li - Frontiers in Neuroscience 2023 cited by 95

  19. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

    Authors: Shimin Zhao, Yan Lin, Wei Xu, Wenqing Jiang, Zhengyu Zha, Pu Wang, Wei Yu, Zhiqiang Li, Ling-Ling Gong, Yingjie Peng, Jianping Ding, Qun‐Ying Lei, Kun‐Liang Guan, Yue Xiong - Science 2009 cited by 1,110

  20. IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives

    Authors: Hui Yang, Dan Ye, Kun‐Liang Guan, Yue Xiong - Clinical Cancer Research 2012 cited by 432

  21. SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense

    Authors: Yue Xiong, Dan Ye, Renqiang Sun, Xiufei Chen, Shiwen Wang, Kun‐Liang Guan, Hongxiu Yu, Yi Wang, Fang Wang, Qi Xu, Mengli Zhang, Lisha Zhou, Pengyuan Yang - EMBO Reports 2016 cited by 297

  22. Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders

    Authors: Meng Cheng, Xufen Yu, Kaylene Lu, Ling Xie, Li Wang, Fanye Meng, Xiaoran Han, Xian Chen, Jing Liu, Yue Xiong, Jian Jin - Journal of Medicinal Chemistry 2020 cited by 181

  23. Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication

    Authors: Christopher M. Murphy, Yanping Xu, Feng Li, Kouki Nio, Natalia Reszka-Blanco, Xiaodong Li, Yaxu Wu, Yanbao Yu, Yue Xiong, Lishan Su - Cell Reports 2016 cited by 317

  24. The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase

    Authors: Chen‐Ying Liu, Zhengyu Zha, Xin Zhou, Heng Zhang, Wei Huang, Di Zhao, Tingting Li, Siew Wee Chan, Chun Jye Lim, Wanjin Hong, Shimin Zhao, Yue Xiong, Qun‐Ying Lei, Kun‐Liang Guan - Journal of Biological Chemistry 2010 cited by 519